© 2018 TripleMed   • All rights reserved  • Design by Brightlands Maastricht Health Campus 
TripleMed
Oxfordlaan 70 
6229EV Maastricht
The Netherlands

Hans is a former President of the College of Surgeons of the Netherlands and a recently retired vascular surgeon from the Kennemer Gasthuis hospital in Haarlem. He therefore has a lifetime’s experience in the treatment of aortic aneurysms using traditional surgery and endovascular techniques.

 

Hans Brom PhD, MD – Chief Medical Officer

Ir. Tjeerd Homsma, MBA - Chief Executive Officer

Tjeerd has over 20 years of experience in de medical devices industry with sr. management roles in development, marketing, sales and production. Tjeerd is a former CEO of Medisse BV – a medtech start up- and PendraCare BV, a medtech company active in the cardiovascular market. In his role as CEO at PendraCare he has developed and brought to market various cardiovascular products like PTA/PTCA Balloon-, Guiding- and Diagnostic- catheters, and negotiated development-, distribution- and supply agreements with Boston Scientific, Cordis, BBraun and Biotronik.

Supervisory Board

Marcel Kannekens, CPA

is a chartered accountant with long experience in both executive and non-executive board positions.  As well as sitting on the boards of several fast moving consumer goods companies, he is a founder and non-exec director of the cardiac diagnostic company, ACS Biomarker. Marcel is a partner at Park Corporate Finance and he is Chairman of the TripleMed supervisory board.  

Rijnhard van Tets

served as member, and until recently as adviser, of the managing board of ABN AMRO Bank. He is Chairman of the supervisory board of Arcadis and NYSE Euronext N.V.; member of the supervisory board of NYSE Euronext Inc., International Flavors & Fragrances IFF Nederland Holding B.V.; non-executive director of Petrofac Ltd

 

Rijnhard van Tets

served as member, and until recently as adviser, of the managing board of ABN AMRO Bank. He is Chairman of the supervisory board of Arcadis and NYSE Euronext N.V.; member of the supervisory board of NYSE Euronext Inc., International Flavors & Fragrances IFF Nederland Holding B.V.; non-executive director of Petrofac Ltd

 

Frans Hora Siccama

is a 30+ years strategic consultant to foreign based multinationals with special (governmental) projects in the Netherlands, and 15+ years turn-around manager for private equity companies. Recent position: Chairman Supervisory Board of a Rotterdam and USA based company specialized in production of filter systems for cleaning of hydraulic- and gearbox oils, sold in 2014 to a Singaporese stock-listed company, whereby the USA operation was sold early 2017  through a MBO to the USA management.  Chairman of two Foundations and shareholder in a number of smaller companies and start-ups. 

is Director at Brightlands Venture Partners, and senior investment manager at Limburg Ventures. Marcel is supervisory board member of several companies, while serving as chairman, advisory committee member or panelmember at European Venture meetings. Prior to his current roles, Marcel was investment manager at DSM Venturing, a major manufacturing company active in nutrition, materials and health (such as biomedical materials and devices) 

Marcel Kloosterman, PhD

served as member, and until recently as adviser, of the managing board of ABN AMRO Bank. He is Chairman of the supervisory board of Arcadis and NYSE Euronext N.V.; member of the supervisory board of NYSE Euronext Inc., International Flavors & Fragrances IFF Nederland Holding B.V.; non-executive director of Petrofac Ltd